MyAverix Finance
NS · Healthcare
Advik Laboratories Ltd (531686)
Pharmaceuticals & Biotechnology
Advik Laboratories Ltd (531686) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $34.60M, P/E ratio is -3.42, net margin is -1,878.2%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 531686
Advik Laboratories Ltd (531686) — FAQ
What is Advik Laboratories Ltd's market cap?
Advik Laboratories Ltd (531686) has a reported market cap of $34.60M (data as of 2026-07-10).
What is 531686's P/E ratio?
The price-to-earnings (P/E) ratio for Advik Laboratories Ltd (531686) is -3.42 (data as of 2026-07-10).
Does Advik Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Advik Laboratories Ltd (531686). Check the MyAverix Finance app for the latest dividend data.
What sector is Advik Laboratories Ltd in?
Advik Laboratories Ltd (531686) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).
What exchange is 531686 listed on?
531686 is listed on NS.
What is Advik Laboratories Ltd's net margin?
Advik Laboratories Ltd (531686) reports a net margin of -1,878.2% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.